Ticker
SCYXCompany Name
SCYNEXIS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -24.1M | -739.78% | $ 3.26M |
3/31/2025 | $ -27.47M | -1044.37% | $ 2.63M |
12/31/2024 | $ -24.01M | -640.92% | $ 3.75M |
9/30/2024 | $ -21.84M | -254.93% | $ 8.57M |
6/30/2024 | $ -10.18M | -105.34% | $ 9.67M |
3/31/2024 | $ 75.08M | 53.48% | $ 140.38M |
12/31/2023 | $ 60.16M | 42.93% | $ 140.14M |
9/30/2023 | $ 45.09M | 33.18% | $ 135.87M |
6/30/2023 | $ 10.16M | 7.49% | $ 135.66M |
3/31/2023 | $ -82.82M | -1496.53% | $ 5.53M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for SCYNEXIS INC is calculated as follows: CF - Operations [ $ -46.24M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]
Minimum
Mar 31, 2022
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |